Scarica l'app Stockscreener
0.00
100.00%
-0.84
Salarius Pharmaceuticals Inc Borsa (SLRX) Ultime notizie
Aug Swings: What are the future prospects of Salarius Pharmaceuticals IncInsider Selling & Weekly Breakout Watchlists - baoquankhu1.vn
Trade Recap: Is Salarius Pharmaceuticals Inc forming a bullish divergence2026 Support & Resistance & Stepwise Swing Trade Plans - baoquankhu1.vn
Aug Summary: Can Salarius Pharmaceuticals Inc continue delivering strong returnsWeekly Trend Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
US Market Recap: Is Salarius Pharmaceuticals Inc subject to activist investor interest2026 Technicals & Reliable Trade Execution Plans - baoquankhu1.vn
Short Squeeze: Can Salarius Pharmaceuticals Inc continue delivering strong returnsPortfolio Performance Report & Accurate Trade Setup Notifications - baoquankhu1.vn
If You Invested $1,000 in Salarius Pharmaceuticals Inc (SLRX) - Stock Titan
Breakout Move: Will Salarius Pharmaceuticals Inc outperform tech stocksTrade Risk Summary & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Gainers Report: Will Salarius Pharmaceuticals Inc stock hit new highs in YEARPrice Action & AI Powered Market Trend Analysis - baoquankhu1.vn
Momentum Shift: Can Salarius Pharmaceuticals Inc outperform under higher oil prices2026 Highlights & Long-Term Capital Growth Strategies - baoquankhu1.vn
Salarius Pharmaceuticals appeals Nasdaq delisting after bid deficiency - MSN
Panic Selling: Is Salarius Pharmaceuticals Inc benefiting from interest rate changesM&A Rumor & Growth Focused Investment Plans - baoquankhu1.vn
Salarius announces planned corporate name change to Decoy Therapeutics - MSN
Analyst Upgrade: Can Salarius Pharmaceuticals Inc. outperform under higher oil prices2026 Movers & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Aug Shorts: Is Salarius Pharmaceuticals Inc. subject to activist investor interestJuly 2025 Gainers & AI Driven Price Predictions - baoquankhu1.vn
Buy Signal: Is Salarius Pharmaceuticals Inc benefiting from interest rate changesMarket Sentiment Summary & Technical Pattern Based Signals - baoquankhu1.vn
Risk Recap: Is Salarius Pharmaceuticals Inc subject to activist investor interestWeekly Trend Report & AI Driven Price Predictions - baoquankhu1.vn
Will Salarius Pharmaceuticals Inc outperform tech stocks2025 Risk Factors & Verified Short-Term Trading Plans - baoquankhu1.vn
SLRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aug Momentum: Can Salarius Pharmaceuticals Inc continue delivering strong returns2025 Geopolitical Influence & High Return Trade Opportunity Guides - baoquankhu1.vn
Aug Gainers: Will Salarius Pharmaceuticals Inc be affected by tariffsDay Trade & High Accuracy Trade Alerts - baoquankhu1.vn
Decoy Therapeutics (NASDAQ: DCOY) wins approval for equity plan and reverse split - Stock Titan
SLRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Levels Update: Can Salarius Pharmaceuticals Inc outperform under higher oil pricesWeekly Earnings Recap & AI Based Trade Execution Alerts - baoquankhu1.vn
Can Salarius Pharmaceuticals Inc weather a recessionSell Signal & Growth Oriented Trading Recommendations - baoquankhu1.vn
Short Covering: Can Salarius Pharmaceuticals Inc benefit from deglobalizationCEO Change & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Is Salarius Pharmaceuticals Inc. benefiting from interest rate changesJuly 2025 Outlook & Verified Chart Pattern Trade Signals - mfd.ru
CVI and Heights disclose 9.9% Decoy Therapeutics (DCOY) warrant stake - Stock Titan
Aug PreEarnings: Is Salarius Pharmaceuticals Inc. benefiting from interest rate changesJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru
What are the future prospects of Salarius Pharmaceuticals Inc.Trend Reversal & Consistent Return Investment Signals - mfd.ru
Aug Breakouts: Is Salarius Pharmaceuticals Inc forming a bullish divergenceWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Value Recap: Can Salarius Pharmaceuticals Inc benefit from deglobalizationMarket Volume Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Signal Recap: What are the future prospects of Salarius Pharmaceuticals Inc2025 Key Highlights & Daily Profit Maximizing Tips - baoquankhu1.vn
Trend Review: Is AMRN a cyclical or defensive stockQuarterly Trade Report & Safe Capital Investment Plans - baoquankhu1.vn
Trend Report: What are the future prospects of Salarius Pharmaceuticals Inc2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Aug Volume: What analysts say about Salarius Pharmaceuticals Inc stock - baoquankhu1.vn
Travel Stocks: Can Salarius Pharmaceuticals Inc weather a recession2025 Market Outlook & AI Driven Stock Reports - baoquankhu1.vn
Aug Analyst Calls: Can Salarius Pharmaceuticals Inc continue delivering strong returnsJuly 2025 Patterns & High Conviction Investment Ideas - baoquankhu1.vn
Short Interest in Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Expands By 20.9% - Defense World
What analysts say about Salarius Pharmaceuticals Inc. stockDividend Stock Watch & Low Risk Investment Plans - Bollywood Helpline
Momentum Shift: Is Salarius Pharmaceuticals Inc benefiting from interest rate changesWeekly Investment Summary & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Meme Stocks: Can Salarius Pharmaceuticals Inc benefit from deglobalizationJuly 2025 Pullbacks & Safe Entry Zone Tips - baoquankhu1.vn
DCOY Stock Price, News & Analysis - Stock Titan
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of A Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - marketscreener.com
US Stocks Recap: Will Salarius Pharmaceuticals Inc. stock benefit from infrastructure spendingMarket Activity Report & Daily Risk Controlled Trade Plans - Bộ Nội Vụ
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - Finviz
Decoy Therapeutics reaches global access commitment agreement to focus on development of a globally accessible, scalable peptide-conjugate manufacturing platform - marketscreener.com
Outbreak-ready antiviral network for low- and middle-income countries - Stock Titan
Salarius Pharmaceuticals, Inc. (DCOY) Stock Live Price, Chart & News - CoinCodex
Forecast Cut: Can Salarius Pharmaceuticals Inc weather a recessionProduct Launch & Safe Entry Zone Identification - baoquankhu1.vn
Salarius Pharmaceuticals shareholders re-elect directors and approve proposals at annual meeting - Investing.com Nigeria
Hanish, director at Salarius, sells shares worth $17 By Investing.com - Investing.com Nigeria
Published on: 2026-01-12 02:10:04 - Улправда
DCOY Stock Price and Chart — BOATS:DCOY - TradingView — Track All Markets
Can Salarius Pharmaceuticals Inc. stock hit analyst price targets2025 Stock Rankings & Risk Managed Investment Signals - ulpravda.ru
Salarius Pharmaceuticals Rebrands as Decoy Therapeutics on Nasdaq - The Globe and Mail
Profit Review: Is Salarius Pharmaceuticals Inc. stock overvalued by current metrics2025 Analyst Calls & Weekly Setup with High ROI Potential - Улправда
Total assets of Salarius Pharmaceuticals, Inc. – NASDAQ:DCOY - TradingView — Track All Markets
Salarius Pharmaceuticals, Inc. Balance Sheet – NASDAQ:DCOY - TradingView — Track All Markets
Is Salarius Pharmaceuticals Inc. (FP10) stock worth buying before Fed actionShare Buyback & Consistent Return Investment Signals - Улправда
Will Salarius Pharmaceuticals Inc. stock maintain growth storyPortfolio Performance Report & Safe Swing Trade Setup Alerts - Улправда
1.52%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):